In breast cancer models, MG induction or GLO1 inhibition can achieve significant anticancer effects by activating the MAPK signaling pathway and decreasing the expression of anti-apoptotic proteins (e.g., Bcl-2, MMP-9) (133). The gene discussed is GLO1; the disease is breast cancer.